Yifan Pharmaceutical(002019.SZ): Concentrated solution of metoprolol tartrate injection received regulatory approval in Singapore.
Yifan Pharmaceuticals (002019.SZ) announced that its wholly-owned subsidiary SciGen Pte. Ltd. has recently received approval from the Health Sciences Authority (HSA) of Singapore for the listing of its pharmaceutical product, Concentrated Catecholamine Bitartrate Injection, for sale in Singapore. This medication is intended for the blood pressure control in adults with severe, acute hypotensive states (can increase blood pressure levels).
Yifan Pharmaceutical (002019.SZ) announced that its wholly-owned subsidiary, SciGen Pte. Ltd., has recently received approval from the Health Sciences Authority of Singapore (HSA) to market and sell their pharmaceutical product Epinephrine Bitartrate Injection Concentrate in Singapore. This product is intended for the control of blood pressure in adults with severe, acute hypotensive states (to increase blood pressure levels).
Related Articles
XUNZHONG (02597): Hu Jun resigns as Chief Financial Officer
Amazon.com, Inc. (AMZN.US)'s $200 billion capital spending shocked its own stock price, but ignited the market for suppliers such as NVIDIA Corporation (NVDA.US) and Marvell (MRVL.US).
YUEXIU PROPERTY (00123): Guangzhou City Construction will publicly issue corporate bonds (first tranche) type 2 with a face interest rate of 2.18% to professional investors in 2026.
XUNZHONG (02597): Hu Jun resigns as Chief Financial Officer
Amazon.com, Inc. (AMZN.US)'s $200 billion capital spending shocked its own stock price, but ignited the market for suppliers such as NVIDIA Corporation (NVDA.US) and Marvell (MRVL.US).
YUEXIU PROPERTY (00123): Guangzhou City Construction will publicly issue corporate bonds (first tranche) type 2 with a face interest rate of 2.18% to professional investors in 2026.
